16 deaths in 2012 directly due to clinical trials: Govt

Image
Press Trust of India New Delhi
Last Updated : Mar 04 2013 | 5:15 PM IST
As many as 436 people died during clinical trials in the country last year, of which only 16 were attributed directly to such experiments.
"As per available data, the number of serious adverse events of deaths in clinical trials reported during the last three years - 2010, 2011 and 2012 - were 668, 438 and 436, respectively," Minister for Health and Family Welfare Ghulam Nabi Azad said in a written reply to a question in the Lok Sabha.
However, deaths attributable to clinical trials were 22, 16 and 16 respectively during these three years, he said.
The minister said government has taken a number of steps to strengthen the approval procedures and monitoring mechanism for clinical trials and to ensure safety, rights and well-being of trial subjects, which includes the amendments notified in the Drugs and Cosmetics Rules, 1945.
As per the rules, the investigator conducting the trial is mandated to ascertain the death and report the same to the Drugs Controller General of India, the sponsor and the Ethics Committee within 24 hours of the occurrence.
In a bid to regulate the booming clinical trial industry in India, government had earlier this month set up four committees to monitor and ensure accountability during such tests that have seen 2,242 deaths in the past five years.
So far, there was no procedure in place to ensure accountability of this hitherto unregulated sector which is worth USD 500 million in India.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 04 2013 | 5:15 PM IST

Next Story